About this trial
To compare the urinary continence rate and long-term oncological outcomes of pelvic-organ preserving radical cystectomy (POPRC) with orthotopic ileal neobladder (OIN) versus standard radical cystectomy(SRC) with OIN.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Female patients aged between 55-75.
Patients those who are diagnosed with organ-confined urothelial carcinoma(<pT3)
Patients those who are capable for radical cystectomy with orthotopic ileal neobladder.
ECOG score between 0-2;
Disqualifiers
Absence of tumour in bladder neck or urethra;
Patients thsoe who are diagnosed distant metastasis before surgery.
Previous history of malignancy of pelvic organs or surgical resection of pelvic organs;
Patients those who are diagnosed with other malignancies.;
Trial design
Parallel
Treatments tested in this trial
POPRC+OIN
Procedure/SurgeryPelvic-organ preserving radical cystectomy with orthotopic ileal neobladder
SRC+OIN
Procedure/SurgeryStandard radical cystectomy with orthotopic ileal neobladder
Treatment groups
Trial outcomes
Primary outcomes
day-time and night-time continence rate
We will use pad-test to evaluate the urinary continence for patients
Secondary outcomes
postoperative sexual function
International index of erectile function-5 (IIEF-5)
perioperative complications rate
perioperative complications rate within 1 month
overall survival
5-year overall survival rate
recurrence-free survival
5-year overall recurrence-free survival rate
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead sponsor
Peking University Third Hospital
Collaborator
This trial is not recruiting at the moment. You can still explore other options: